» Articles » PMID: 9332762

Determinants for Genital Human Papillomavirus (HPV) Infection in 1000 Randomly Chosen Young Danish Women with Normal Pap Smear: Are There Different Risk Profiles for Oncogenic and Nononcogenic HPV Types?

Overview
Date 1997 Oct 23
PMID 9332762
Citations 37
Authors
Affiliations
Soon will be listed here.
Abstract

Most studies of risk factors for human papillomavirus (HPV) DNA detection have focused on overall HPV positivity and have not examined determinants for high-risk and low-risk HPV types separately. We studied risk determinants for genital HPV infection in 1000 randomly chosen women (20-29 years) with normal cervical cytology from Copenhagen, Denmark. All women had a personal interview, a Pap smear, and cervical swabs for HPV DNA detection using a PCR technique. On the basis of their association with cervical cancer, the HPV types were categorized as belonging to a high-risk group ("oncogenic types") or a low-risk group ("nononcogenic types"). The overall HPV detection rate was 15.4%. Of HPV-positive women, 74% had oncogenic HPV types, and 30% had nononcogenic HPV types. Younger age and lifetime measures of sexual activity (notably, number of partners) were the main risk factors for the oncogenic HPV types. Furthermore, a previous Chlamydia infection was associated with the high-risk HPV types. In contrast, the most important determinants for nononcogenic HPV infection were contraceptive variables related to the physical protection of the cervix (condom or diaphragm) and number of partners in the last 4 or 12 months. Our study confirms the venereal nature of HPV infection. We hypothesize that the low-risk HPV infection, which correlates with recent sexual behavior, may be more transient than infection with the oncogenic HPV types, which correlates with lifetime exposure measurements of sexual habits.

Citing Articles

Factors associated with positive human papillomavirus (HPV) test results in cervical precancer screening: a cross-sectional study at Souro Sanou National Teaching Hospital (SSNTH) in Bobo Dioulasso, Burkina Faso.

Meda Z, Hien H, Traore T, Ouattara C, Ramde Z, Ilboudo B BMC Public Health. 2024; 24(1):2900.

PMID: 39434024 PMC: 11492753. DOI: 10.1186/s12889-024-20389-w.


Impact of human papillomavirus age-related prevalence and vaccination levels on interpretation of cervical screening modalities: a modelling study.

Grimes D BMJ Open. 2024; 14(2):e078551.

PMID: 38309749 PMC: 10840029. DOI: 10.1136/bmjopen-2023-078551.


Risk of Anogenital Warts in Renal Transplant Recipients Compared with Immunocompetent Controls: A Cross-sectional Clinical Study.

Larsen H, Thomsen L, Haedersdal M, Lok T, Hansen J, Schwartz Sorensen S Acta Derm Venereol. 2021; 101(7):adv00497.

PMID: 34184064 PMC: 9413648. DOI: 10.2340/00015555-3858.


Differences in Factors Associated With High- and Low-Risk Oral Human Papillomavirus Genotypes in Men.

Bettampadi D, Dickey B, Abrahamsen M, Sirak B, Baggio M, Galan L J Infect Dis. 2020; 223(12):2099-2107.

PMID: 33151300 PMC: 8205625. DOI: 10.1093/infdis/jiaa693.


Prevalence and correlation of human papillomavirus genotypes with clinical factors in cervical samples from Mexican women.

Hernandez-Rosas F, Orozco-Hernandez E, Maza-Sanchez L, Salgado-Garcia P, Navarro-Vidal E, de Leon-Bautista M Exp Biol Med (Maywood). 2020; 246(1):48-56.

PMID: 32962407 PMC: 7797998. DOI: 10.1177/1535370220959747.